January 2026 in “JPRAS Open” In this pilot study, PDLLA scalp microinjections showed improvement in physician-rated Global Aesthetic Improvement Scale scores over 12-24 weeks for 90% of patients with non-scarring alopecia, with no serious adverse events reported, although findings remain preliminary due to methodological limitations.
15 citations
,
January 2020 in “RSC advances” In this study, researchers developed a new Supported Ionic Liquid Phase palladium catalyst that showed effectiveness in aminocarbonylation reactions for synthesizing pharmaceutical compounds like CX-546 and a precursor of Finasteride, though results were sensitive to substrate variations and prompted palladium leaching concerns.
8 citations
,
September 2019 in “Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity” This case report illustrates that pellagra can develop in patients with anorexia nervosa without typical signs of severe malnutrition, responding rapidly to nicotinamide and tryptophan therapy.
2 citations
,
May 2011 in “British Journal of Dermatology” This review discusses the diagnosis and treatment of pellagra, emphasizing the importance of evaluating serum niacin levels in photosensitive patients with certain risk factors, and reports no new clinical results.
October 2019 in “Postgraduate Medical Journal” This case report describes a patient with pellagrous dermatitis related to chronic alcoholism, whose symptoms resolved within two weeks following treatment with nicotinamide, vitamin B12, and thiamine.